エクソソーム療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Exosome Therapy Market Insights, Forecast to 2028

• レポートコード：QY2207C3823 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のエクソソーム療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエクソソーム療法の世界市場のxxx％を占める「直接治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のエクソソーム療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのエクソソーム療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのエクソソーム療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 エクソソーム療法のグローバル主要メーカーには、United Therapeutics Corporation、Codiak BioSciences、EngEx™、Esperite Group、ArunA Biomedical、Evox Therapeutics、NeurExo Sciences、Tavec Pharmaceuticals、AEGLE Therapeutics、Avalon GloboCare、AlligatorBioscience、Capricor Therapeutics、Stem Cell Medicine、CellTex Therapeuticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 エクソソーム療法市場は、種類と用途によって区分されます。世界のエクソソーム療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 直接治療、ドラッグデリバリービークル 【用途別セグメント】 病院、クリニック、研究機関 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - エクソソーム療法製品概要 - 種類別市場（直接治療、ドラッグデリバリービークル） - 用途別市場（病院、クリニック、研究機関） - 調査の目的 ・エグゼクティブサマリー - 世界のエクソソーム療法販売量予測2017-2028 - 世界のエクソソーム療法売上予測2017-2028 - エクソソーム療法の地域別販売量 - エクソソーム療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別エクソソーム療法販売量 - 主要メーカー別エクソソーム療法売上 - 主要メーカー別エクソソーム療法価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（直接治療、ドラッグデリバリービークル） - エクソソーム療法の種類別販売量 - エクソソーム療法の種類別売上 - エクソソーム療法の種類別価格 ・用途別市場規模（病院、クリニック、研究機関） - エクソソーム療法の用途別販売量 - エクソソーム療法の用途別売上 - エクソソーム療法の用途別価格 ・北米市場 - 北米のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのエクソソーム療法市場規模（種類別、用途別） - 主要国別のエクソソーム療法市場規模（トルコ、サウジアラビア） ・企業情報 United Therapeutics Corporation、Codiak BioSciences、EngEx™、Esperite Group、ArunA Biomedical、Evox Therapeutics、NeurExo Sciences、Tavec Pharmaceuticals、AEGLE Therapeutics、Avalon GloboCare、AlligatorBioscience、Capricor Therapeutics、Stem Cell Medicine、CellTex Therapeutics ・産業チェーン及び販売チャネル分析 - エクソソーム療法の産業チェーン分析 - エクソソーム療法の原材料 - エクソソーム療法の生産プロセス - エクソソーム療法の販売及びマーケティング - エクソソーム療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - エクソソーム療法の産業動向 - エクソソーム療法のマーケットドライバー - エクソソーム療法の課題 - エクソソーム療法の阻害要因 ・主な調査結果

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
Market Analysis and Insights: Global Exosome Therapy Market
The global Exosome Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Direct Treatment accounting for % of the Exosome Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Exosome Therapy market size is valued at US$ million in 2021, while the North America and Europe Exosome Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Exosome Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Therapy market.
Global Exosome Therapy Scope and Market Size
Exosome Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Exosome Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Direct Treatment
Drug Delivery Vehicle
Segment by Application
Hospital
Clinic
Research Institutions
By Company
United Therapeutics Corporation
Codiak BioSciences
EngEx™
Esperite Group
ArunA Biomedical
Evox Therapeutics
NeurExo Sciences
Tavec Pharmaceuticals
AEGLE Therapeutics
Avalon GloboCare
AlligatorBioscience
Capricor Therapeutics
Stem Cell Medicine
CellTex Therapeutics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2017-2028)
2.2 Exosome Therapy Growth Trends by Region
2.2.1 Exosome Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Exosome Therapy Historic Market Size by Region (2017-2022)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2023-2028)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapy Players by Revenue
3.1.1 Global Top Exosome Therapy Players by Revenue (2017-2022)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Therapy Revenue
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2021
3.5 Exosome Therapy Key Players Head office and Area Served
3.6 Key Players Exosome Therapy Product Solution and Service
3.7 Date of Enter into Exosome Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2017-2022)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2023-2028)
5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2017-2022)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Exosome Therapy Market Size (2017-2028)
6.2 North America Exosome Therapy Market Size by Type
6.2.1 North America Exosome Therapy Market Size by Type (2017-2022)
6.2.2 North America Exosome Therapy Market Size by Type (2023-2028)
6.2.3 North America Exosome Therapy Market Share by Type (2017-2028)
6.3 North America Exosome Therapy Market Size by Application
6.3.1 North America Exosome Therapy Market Size by Application (2017-2022)
6.3.2 North America Exosome Therapy Market Size by Application (2023-2028)
6.3.3 North America Exosome Therapy Market Share by Application (2017-2028)
6.4 North America Exosome Therapy Market Size by Country
6.4.1 North America Exosome Therapy Market Size by Country (2017-2022)
6.4.2 North America Exosome Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Exosome Therapy Market Size (2017-2028)
7.2 Europe Exosome Therapy Market Size by Type
7.2.1 Europe Exosome Therapy Market Size by Type (2017-2022)
7.2.2 Europe Exosome Therapy Market Size by Type (2023-2028)
7.2.3 Europe Exosome Therapy Market Share by Type (2017-2028)
7.3 Europe Exosome Therapy Market Size by Application
7.3.1 Europe Exosome Therapy Market Size by Application (2017-2022)
7.3.2 Europe Exosome Therapy Market Size by Application (2023-2028)
7.3.3 Europe Exosome Therapy Market Share by Application (2017-2028)
7.4 Europe Exosome Therapy Market Size by Country
7.4.1 Europe Exosome Therapy Market Size by Country (2017-2022)
7.4.2 Europe Exosome Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapy Market Size (2017-2028)
8.2 Asia-Pacific Exosome Therapy Market Size by Type
8.2.1 Asia-Pacific Exosome Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Exosome Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Exosome Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Exosome Therapy Market Size by Application
8.3.1 Asia-Pacific Exosome Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Exosome Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Exosome Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Exosome Therapy Market Size by Region
8.4.1 Asia-Pacific Exosome Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Exosome Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Exosome Therapy Market Size (2017-2028)
9.2 Latin America Exosome Therapy Market Size by Type
9.2.1 Latin America Exosome Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Exosome Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Exosome Therapy Market Share by Type (2017-2028)
9.3 Latin America Exosome Therapy Market Size by Application
9.3.1 Latin America Exosome Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Exosome Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Exosome Therapy Market Share by Application (2017-2028)
9.4 Latin America Exosome Therapy Market Size by Country
9.4.1 Latin America Exosome Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Exosome Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapy Market Size (2017-2028)
10.2 Middle East & Africa Exosome Therapy Market Size by Type
10.2.1 Middle East & Africa Exosome Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Exosome Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Exosome Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Exosome Therapy Market Size by Application
10.3.1 Middle East & Africa Exosome Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Exosome Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Exosome Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Exosome Therapy Market Size by Country
10.4.1 Middle East & Africa Exosome Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Exosome Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Details
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022)
11.1.5 United Therapeutics Corporation Recent Developments
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022)
11.2.5 Codiak BioSciences Recent Developments
11.3 EngEx™
11.3.1 EngEx™ Company Details
11.3.2 EngEx™ Business Overview
11.3.3 EngEx™ Exosome Therapy Introduction
11.3.4 EngEx™ Revenue in Exosome Therapy Business (2017-2022)
11.3.5 EngEx™ Recent Developments
11.4 Esperite Group
11.4.1 Esperite Group Company Details
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2017-2022)
11.4.5 Esperite Group Recent Developments
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Details
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022)
11.5.5 ArunA Biomedical Recent Developments
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.6.5 Evox Therapeutics Recent Developments
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Details
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022)
11.7.5 NeurExo Sciences Recent Developments
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Details
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022)
11.8.5 Tavec Pharmaceuticals Recent Developments
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Details
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.9.5 AEGLE Therapeutics Recent Developments
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Details
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022)
11.10.5 Avalon GloboCare Recent Developments
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Details
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022)
11.11.5 AlligatorBioscience Recent Developments
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Details
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.12.5 Capricor Therapeutics Recent Developments
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Details
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022)
11.13.5 Stem Cell Medicine Recent Developments
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Details
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022)
11.14.5 CellTex Therapeutics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Exosome Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Direct Treatment
Table 3. Key Players of Drug Delivery Vehicle
Table 4. Global Exosome Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Exosome Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Exosome Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Exosome Therapy Market Share by Region (2017-2022)
Table 8. Global Exosome Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Exosome Therapy Market Share by Region (2023-2028)
Table 10. Exosome Therapy Market Trends
Table 11. Exosome Therapy Market Drivers
Table 12. Exosome Therapy Market Challenges
Table 13. Exosome Therapy Market Restraints
Table 14. Global Exosome Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Exosome Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Exosome Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2021)
Table 17. Ranking of Global Top Exosome Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Exosome Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Exosome Therapy Product Solution and Service
Table 21. Date of Enter into Exosome Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Exosome Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Exosome Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Exosome Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Exosome Therapy Revenue Share by Application (2017-2022)
Table 29. Global Exosome Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Exosome Therapy Revenue Share by Application (2023-2028)
Table 31. North America Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Exosome Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Exosome Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Exosome Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Exosome Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Exosome Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Exosome Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Exosome Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Exosome Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Exosome Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Exosome Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Exosome Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Exosome Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Exosome Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Exosome Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Exosome Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Exosome Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. United Therapeutics Corporation Company Details
Table 62. United Therapeutics Corporation Business Overview
Table 63. United Therapeutics Corporation Exosome Therapy Product
Table 64. United Therapeutics Corporation Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 65. United Therapeutics Corporation Recent Developments
Table 66. Codiak BioSciences Company Details
Table 67. Codiak BioSciences Business Overview
Table 68. Codiak BioSciences Exosome Therapy Product
Table 69. Codiak BioSciences Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 70. Codiak BioSciences Recent Developments
Table 71. EngEx™ Company Details
Table 72. EngEx™ Business Overview
Table 73. EngEx™ Exosome Therapy Product
Table 74. EngEx™ Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 75. EngEx™ Recent Developments
Table 76. Esperite Group Company Details
Table 77. Esperite Group Business Overview
Table 78. Esperite Group Exosome Therapy Product
Table 79. Esperite Group Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 80. Esperite Group Recent Developments
Table 81. ArunA Biomedical Company Details
Table 82. ArunA Biomedical Business Overview
Table 83. ArunA Biomedical Exosome Therapy Product
Table 84. ArunA Biomedical Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 85. ArunA Biomedical Recent Developments
Table 86. Evox Therapeutics Company Details
Table 87. Evox Therapeutics Business Overview
Table 88. Evox Therapeutics Exosome Therapy Product
Table 89. Evox Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 90. Evox Therapeutics Recent Developments
Table 91. NeurExo Sciences Company Details
Table 92. NeurExo Sciences Business Overview
Table 93. NeurExo Sciences Exosome Therapy Product
Table 94. NeurExo Sciences Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 95. NeurExo Sciences Recent Developments
Table 96. Tavec Pharmaceuticals Company Details
Table 97. Tavec Pharmaceuticals Business Overview
Table 98. Tavec Pharmaceuticals Exosome Therapy Product
Table 99. Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 100. Tavec Pharmaceuticals Recent Developments
Table 101. AEGLE Therapeutics Company Details
Table 102. AEGLE Therapeutics Business Overview
Table 103. AEGLE Therapeutics Exosome Therapy Product
Table 104. AEGLE Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 105. AEGLE Therapeutics Recent Developments
Table 106. Avalon GloboCare Company Details
Table 107. Avalon GloboCare Business Overview
Table 108. Avalon GloboCare Exosome Therapy Product
Table 109. Avalon GloboCare Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 110. Avalon GloboCare Recent Developments
Table 111. AlligatorBioscience Company Details
Table 112. AlligatorBioscience Business Overview
Table 113. AlligatorBioscience Exosome Therapy Product
Table 114. AlligatorBioscience Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 115. AlligatorBioscience Recent Developments
Table 116. Capricor Therapeutics Company Details
Table 117. Capricor Therapeutics Business Overview
Table 118. Capricor Therapeutics Exosome Therapy Product
Table 119. Capricor Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 120. Capricor Therapeutics Recent Developments
Table 121. Stem Cell Medicine Company Details
Table 122. Stem Cell Medicine Business Overview
Table 123. Stem Cell Medicine Exosome Therapy Product
Table 124. Stem Cell Medicine Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 125. Stem Cell Medicine Recent Developments
Table 126. CellTex Therapeutics Company Details
Table 127. CellTex Therapeutics Business Overview
Table 128. CellTex Therapeutics Exosome Therapy Product
Table 129. CellTex Therapeutics Revenue in Exosome Therapy Business (2017-2022) & (US$ Million)
Table 130. CellTex Therapeutics Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapy Market Share by Type: 2021 VS 2028
Figure 2. Direct Treatment Features
Figure 3. Drug Delivery Vehicle Features
Figure 4. Global Exosome Therapy Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Exosome Therapy Report Years Considered
Figure 9. Global Exosome Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Exosome Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Exosome Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Exosome Therapy Market Share by Players in 2021
Figure 13. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Exosome Therapy Revenue in 2021
Figure 15. North America Exosome Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Exosome Therapy Market Size Market Share by Type (2017-2028)
Figure 17. North America Exosome Therapy Market Size Market Share by Application (2017-2028)
Figure 18. North America Exosome Therapy Market Size Share by Country (2017-2028)
Figure 19. United States Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Exosome Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Exosome Therapy Market Size Market Share by Type (2017-2028)
Figure 23. Europe Exosome Therapy Market Size Market Share by Application (2017-2028)
Figure 24. Europe Exosome Therapy Market Size Share by Country (2017-2028)
Figure 25. Germany Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Exosome Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Exosome Therapy Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Exosome Therapy Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Exosome Therapy Market Size Share by Region (2017-2028)
Figure 35. China Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Exosome Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Exosome Therapy Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Exosome Therapy Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Exosome Therapy Market Size Share by Country (2017-2028)
Figure 45. Mexico Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Exosome Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Exosome Therapy Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Exosome Therapy Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Exosome Therapy Market Size Share by Country (2017-2028)
Figure 51. Turkey Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Exosome Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. United Therapeutics Corporation Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 55. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 56. EngEx™ Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 57. Esperite Group Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 58. ArunA Biomedical Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 59. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 60. NeurExo Sciences Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 61. Tavec Pharmaceuticals Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 62. AEGLE Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 63. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 64. AlligatorBioscience Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 65. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 66. Stem Cell Medicine Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 67. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---